Concurrent chemoradiotherapy followed by adjuvant cisplatin–gemcitabine versus cisplatin–fluorouracil chemotherapy for N2–3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial
Li‐Ting Liu, Huai Liu, Ying Huang, Jin‐Hao Yang, Si-Yi Xie, Yuanyuan Li, Shanshan Guo, Bin Qi, Xiaoyun Li, Dongping Chen, Feng Jin, Xue-Song Sun, Zhen‐Chong Yang, Sai‐Lan Liu, Dong–Hua Luo, Jibin Li, Qing Liu, Pan Wang, Ling Guo, Hao‐Yuan Mo, Fang Qiu, Qi Yang, Yu-Jing Liang, Guodong Jia, Dong‐Xiang Wen, Jin‐Jie Yan, Chong Zhao, Qiuyan Chen, Rui Sun, Lin‐Quan Tang, Hai‐Qiang Mai
Topics & Concepts
MedicineNasopharyngeal carcinomaRegimenGemcitabineInternal medicineFluorouracilClinical endpointChemoradiotherapyCisplatinOncologyPopulationRadiation therapySurgeryRandomized controlled trialChemotherapyEnvironmental healthHead and Neck Cancer StudiesHead and Neck Surgical OncologyEsophageal Cancer Research and Treatment